1. Home
  2. BIIB vs RKT Comparison

BIIB vs RKT Comparison

Compare BIIB & RKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biogen Inc.

BIIB

Biogen Inc.

N/A

Current Price

$249.28

Market Cap

34.5B

Sector

Health Care

ML Signal

N/A

Logo Rocket Companies Inc.

RKT

Rocket Companies Inc.

N/A

Current Price

$13.37

Market Cap

33.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIIB
RKT
Founded
1978
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
34.5B
33.0B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
BIIB
RKT
Price
$249.28
$13.37
Analyst Decision
Buy
Buy
Analyst Count
36
16
Target Price
★ $268.26
$14.75
AVG Volume (30 Days)
1.1M
★ 34.9M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.66
0.43
Revenue
★ $9,890,600,000.00
N/A
Revenue This Year
$6.92
$49.22
Revenue Next Year
$1.91
$0.01
P/E Ratio
$94.29
★ $30.79
Revenue Growth
★ 2.22
N/A
52 Week Low
$160.36
$10.18
52 Week High
$261.00
$24.36

Technical Indicators

Market Signals
Indicator
BIIB
RKT
Relative Strength Index (RSI) 54.04 51.68
Support Level $240.00 $12.52
Resistance Level $259.89 $14.91
Average True Range (ATR) 7.29 0.59
MACD -1.09 -0.09
Stochastic Oscillator 43.79 34.94

Price Performance

Historical Comparison
BIIB
RKT

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.

Share on Social Networks: